Navigation Links
Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
Date:10/31/2007

atin, but by using micellar nanoparticles, we believe we can develop a new, more effective DACH-platin anticancer drug with possible lower side effects.

The basic technology of this formulation was invented by Professor Kataoka of the University of Tokyo. The technology was licensed in from TOUDAI TLO Ltd. The basic Japanese patent for DACH-platin micelle has been granted as Patent No. 39955992 in May 2007.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed three products: Eloxatin(R), Decapeptyl(R) and Trelstar(R) with global combined sales in excess of $2.6 billion in 2006.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com.

About NanoCarrier Co., Ltd.

NanoCarrier is a biotech that focuses on the research and development of drugs primarily in the field of cancer with micellar nanoparticles technology. Micellar nanoparticles (also known as polymeric micelle) are formed from biocompatible block copolymers which consist of a hydrophilic polymer, polyethyleneglycol (PEG), and a hydrophobic polymer, polyamino acid derivative.

By encapsulating drugs efficiently inside, micellar nanoparticles work as functional particles that stay in bloodstream for a long period of time and deliver drugs preferentially to targeted sites, thus minimizing unfavourable side effects and impro
'/>"/>

SOURCE The Debiopharm Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy to Market Debiopharms New Drug in India
2. Georgia: Indian doctors license cancelled
3. US Government Licenses New Hypertension Drug
4. Proposal to license Ayurveda Practitioners in the US
5. Genomatix Licensed By Bayer Healthcare
6. Panacea Biotec In-Licenses FMD Vaccine
7. Test for Esophageal Reflux Licensed to Bayer by University
8. Thailand Goes Ahead With Licenses for Generic Drugs
9. Swedish Biotech Licenses HIV Drug to China for Development
10. More Foreign Trained Doctors Receive Licenses
11. FDA Licenses First US Vaccine Against Avian Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Alice Branton, ... 5-day tour in India. During her stay, she met with the leading ... Wellness™ and Transformational Leader/Internationally Beloved Spiritual Master Mahendra Trivedi to develop highly ...
(Date:6/30/2015)... ... ... known as Body Brushing) is a wonderful daily practice all year round. In summer, ... the elements. , Dry Skin Brushing takes only 10 minutes per day, but delivers great ... on skin's surface. Skin is the largest organ of elimination and brushing helps the process. ...
(Date:6/30/2015)... Jersey City, NJ (PRWEB) , ... June 30, 2015 , ... ... devices, today announced the general availability of three new apps – AvePoint Watermark, ... and SharePoint Online. With the addition of these apps, workers can better streamline everyday ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Some may ... – and the ongoing efforts of New York State Athletic Trainers’ Association (NYSATA) and ... NYSATA was recognized with two national awards, and a number of members also received ...
(Date:6/30/2015)... ... ... Intellitec Solutions has announced they will be hosting two webinars to answer ... and new procedures involved with updating the cloud version of Dynamics CRM, attendance is ... user interface and what it will mean for end users, critical items that need ...
Breaking Medicine News(10 mins):Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:Intellitec Solutions to Host Microsoft CRM 2015 Update Webinar 2
... billion people suffer from preventable, treatable diseases around,the ... director Global Health Progress, TOYAKO, Japan, July ... World Health Organization (WHO) and,the Drugs for Neglected ... to,recognize the importance of neglected diseases as a ...
... July 8 Bristol-Myers Squibb, an,international pharmaceutical manufacturer, ... at multiple industrial facilities around,the country at a ... of,the Clean Air Act, U.S. Environmental Protection Agency ... an agreement filed in federal court in Evansville, ...
... which patients are most likely to respond to Herceptin , , ... determine whether a breast cancer patient is likely to respond ... by the U.S. Food and Drug Administration. , ... of the HER2 gene, which regulates the growth of cancer ...
... At 12:00 noon on July 8, 2008, J.,Douglas ... P.C.,filed the first drug product liability action in ... former Governor Engler,s grant of immunity,to drug manufacturers., ... was filed in the United,States District Court, Eastern ...
... of scientific evidence shows that cholesterol-reducing medications known as ... safety of these medications has been well documented, as ... prescription for statins take the drug for less than ... cost, adverse effects, poor understanding of statin benefits and ...
... to Serve Seniors and Disabled Through ... BEACH, Calif., July 8 Arthur Henkel, a ... been appointed vice,president of mergers and acquisitions for ... announced today. With this appointment, the,not-for- profit health ...
Cached Medicine News:Health News:Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases 2Health News:Bristol-Myers Squibb Agrees to Clean Air Act Upgrades 2Health News:Bristol-Myers Squibb Agrees to Clean Air Act Upgrades 3Health News:FDA Approves Genetic Test for Breast Cancer 2Health News:National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan 2Health News:Fish oil and red yeast rice studied for lowering blood cholesterol 2Health News:SCAN Health Plan Appoints Arthur Henkel Vice President of Mergers and Acquisitions 2
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... -- Allergan plc (NYSE: AGN ) today announced ... financial results on Thursday, August 6, 2015, prior ... Company will host a conference call and webcast ... August 6, 2015 to discuss its financial results. The ... Canada (877) 251-7980, International (706) ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), ... development, manufacture and sale of enzyme and protein ... industries, today announced financial results for the quarter ... in this press release should be read in ...
... Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a ... equipment to medical institutions, announced today that Encore ... significant growth from Encore Medical Staffing operations in ... started this franchise in December, 2010," says Dr. ...
Cached Medicine Technology:Dyadic International Reports 2011 First Quarter Financial Results 2Dyadic International Reports 2011 First Quarter Financial Results 3Dyadic International Reports 2011 First Quarter Financial Results 4Dyadic International Reports 2011 First Quarter Financial Results 5Southern Home Medical Equipment Reports Significant Growth from Encore Franchisees 2
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
Medicine Products: